Created at:1/13/2025
Palifermin is a specially designed protein medication that helps protect and heal the delicate tissues in your mouth and throat during intense cancer treatments. If you or someone you care about is facing certain types of cancer therapy, your medical team might recommend this supportive treatment to help prevent painful mouth sores and other complications.
This medication works like a gentle guardian for the soft tissues that line your mouth, throat, and digestive tract. It's given through an IV before and after specific cancer treatments to help your body's natural healing processes stay strong when they're under stress.
Palifermin is a man-made version of a natural protein called keratinocyte growth factor (KGF) that your body normally produces. Think of it as a specialized repair crew that specifically targets the cells lining your mouth, throat, and digestive system.
The medication belongs to a class called growth factors, which are proteins that help cells grow, divide, and repair themselves. Scientists created palifermin by modifying the natural KGF to make it more stable and effective when used as a medicine.
This isn't a cancer treatment itself, but rather a supportive therapy that helps protect healthy tissues while you're receiving other necessary treatments. It's like having extra reinforcement for the parts of your body that are most vulnerable during intensive medical procedures.
Palifermin is primarily used to prevent severe mouth sores (called oral mucositis) in people receiving high-dose chemotherapy and radiation therapy before bone marrow transplants. These treatments can be life-saving but often damage the healthy cells that line your mouth and throat.
Your doctor might recommend palifermin if you're preparing for a hematopoietic stem cell transplant, particularly if you have blood cancers like leukemia, lymphoma, or multiple myeloma. The medication is specifically approved for patients who will receive conditioning treatments that are known to cause severe mouth and throat complications.
The goal is to help you get through your cancer treatment with less pain and fewer complications. When mouth sores are prevented or reduced, you're more likely to maintain proper nutrition, have fewer infections, and experience less overall discomfort during your recovery.
Palifermin works by stimulating the growth and protection of epithelial cells, which are the cells that form the protective lining of your mouth, throat, and digestive tract. When these cells are healthy and actively renewing themselves, they're better able to withstand the effects of intensive cancer treatments.
This medication is considered a targeted supportive therapy rather than a strong or weak treatment in the traditional sense. It's specifically designed to work on certain types of cells without affecting your cancer treatment's effectiveness.
The protein binds to specific receptors on your epithelial cells, sending signals that encourage them to grow, multiply, and repair themselves more quickly. This process helps create a stronger, more resilient barrier in your mouth and throat before the challenging treatments begin.
Having said that, palifermin also helps these same cells recover more quickly after treatment damage occurs. It's like having a skilled repair team that works both to strengthen your defenses ahead of time and to fix any damage that does happen.
Palifermin is given only through an intravenous (IV) line by trained healthcare professionals in a hospital or clinic setting. You won't take this medication at home or by mouth.
The typical schedule involves receiving three doses before your conditioning treatment begins, followed by three more doses after your stem cell transplant. Your medical team will space these doses carefully, usually giving them on consecutive days.
You don't need to do anything special to prepare for your palifermin infusion. Unlike some medications, it doesn't require you to eat or avoid eating beforehand. The IV infusion itself usually takes about 15-30 minutes.
Your healthcare team will monitor you during and after each dose to make sure you're tolerating the medication well. They'll also coordinate the timing with your other treatments to ensure the best possible protection for your mouth and throat tissues.
The standard course of palifermin treatment is typically completed within about two weeks, consisting of six total doses given at specific intervals. This isn't a medication you'll take for months or years.
Your doctor will give you three doses before your conditioning treatment starts, then three more doses after your stem cell transplant. The exact timing depends on your specific treatment schedule and how your body responds.
The short treatment duration is intentional and carefully planned. Palifermin is designed to provide protection during the most vulnerable period of your cancer treatment, when your mouth and throat tissues are at highest risk for damage.
Once you've completed the full course and your mouth tissues have healed, you typically won't need additional palifermin treatments unless you undergo similar intensive therapies in the future.
Most people tolerate palifermin quite well, especially considering the intensity of the treatments it's meant to support. The side effects tend to be manageable and temporary, resolving once your treatment course is complete.
Let's start with the most common side effects you might experience, which affect many people who receive this medication:
These common reactions are generally your body's way of responding to the increased cell growth and repair activity. Most people find these effects tolerable and temporary.
Some people experience less common but still manageable side effects that your medical team will monitor for:
Now, let's discuss the rare but more serious side effects that require immediate medical attention. While these don't happen often, it's important to be aware of them:
Your healthcare team will monitor you closely for any concerning reactions and will know exactly how to manage them if they occur. Remember that the benefits of preventing severe mouth sores typically outweigh these potential risks for most patients.
Palifermin isn't suitable for everyone, and your doctor will carefully evaluate whether it's right for your specific situation. The decision involves weighing the benefits against potential risks based on your individual health profile.
You should not receive palifermin if you have a known allergy to the medication itself, any of its components, or to E. coli-derived proteins. Since palifermin is produced using E. coli bacteria, people with severe allergies to E. coli-derived products need alternative approaches.
Your medical team will also exercise extra caution if you have certain types of cancer. Palifermin can potentially stimulate the growth of some cancer cells that have specific receptors, so it's not recommended for certain non-blood cancers.
People with active, uncontrolled infections may need to wait until their infection is treated before starting palifermin. Your immune system needs to be in the best possible condition to benefit from this supportive therapy.
If you're pregnant or breastfeeding, your doctor will need to carefully consider the risks and benefits. While there's limited data on palifermin use during pregnancy, the medication is typically reserved for life-threatening situations where the benefits clearly outweigh potential risks.
Palifermin is available under the brand name Kepivance, which is the most commonly recognized name for this medication. Kepivance is manufactured by Sobi (Swedish Orphan Biovitrum) and is the primary brand available in most countries.
You might see this medication referred to by its generic name, palifermin, or by its brand name, Kepivance, depending on your healthcare setting. Both names refer to the same medication with the same active ingredient.
In some regions, the medication might be available under different brand names or through different manufacturers, but the active ingredient and therapeutic effects remain the same. Your healthcare team will ensure you receive the appropriate formulation regardless of the specific brand name used.
Currently, there are no direct alternatives to palifermin that work in exactly the same way. It's the only FDA-approved medication specifically designed to prevent oral mucositis in patients undergoing high-dose chemotherapy and radiation before stem cell transplants.
However, your medical team might use other supportive approaches alongside or instead of palifermin, depending on your specific situation. These alternative strategies focus on managing symptoms and promoting healing through different mechanisms.
Some healthcare providers use oral care protocols that include special mouthwashes, coating agents, or pain management strategies. These approaches can be helpful but don't provide the same targeted cellular protection that palifermin offers.
Low-level laser therapy and certain nutritional supplements have shown promise in some studies, but they haven't been proven to be as effective as palifermin for preventing severe mouth sores in high-risk patients.
Your doctor will recommend the best approach based on your specific treatment plan, risk factors, and overall health condition. Sometimes a combination of strategies works better than relying on any single approach.
Palifermin is currently considered the gold standard for preventing severe oral mucositis in patients undergoing high-dose conditioning treatments before stem cell transplants. Clinical studies have consistently shown its effectiveness in reducing both the severity and duration of mouth sores.
When compared to standard oral care alone, palifermin significantly reduces the incidence of severe mouth sores from about 98% to around 63% in high-risk patients. This represents a substantial improvement in quality of life during an already challenging treatment period.
The medication has also been shown to reduce the need for narcotic pain medications and decrease the duration of severe mouth pain. Many patients who receive palifermin report being able to eat and drink more comfortably during their treatment recovery.
However, "better" depends on individual circumstances. Some patients may not be candidates for palifermin due to their specific type of cancer or other health factors. In these cases, alternative supportive care approaches become the best available option.
Your healthcare team will consider all available options and recommend the approach that offers the best balance of benefits and risks for your unique situation.
Q1:Is Palifermin Safe for People with Diabetes?
Palifermin is generally considered safe for people with diabetes, but your medical team will monitor you extra carefully. The medication doesn't directly affect blood sugar levels, but the stress of cancer treatment can sometimes make diabetes management more challenging.
Your healthcare providers will coordinate with your diabetes care team to ensure your blood sugar remains well-controlled throughout your treatment. They might adjust your diabetes medications or monitoring schedule to account for the overall stress your body is experiencing.
The benefits of preventing severe mouth sores often outweigh the potential complications for people with diabetes, especially since maintaining good nutrition becomes even more important when managing both conditions.
Q2:What Should I Do If I Accidentally Receive Too Much Palifermin?
Since palifermin is given by healthcare professionals in a controlled medical setting, accidental overdoses are extremely rare. Your medical team carefully calculates and double-checks your dose before each administration.
If you're concerned about receiving too much medication, don't hesitate to ask your healthcare team about the dosing process. They can explain how they calculate your specific dose and what safety measures are in place.
In the unlikely event of a dosing error, your medical team is trained to recognize and manage any complications immediately. They have protocols in place to monitor for and address any adverse reactions.
Q3:What Should I Do If I Miss a Dose of Palifermin?
If you miss a scheduled palifermin dose, contact your healthcare team immediately to discuss rescheduling. The timing of palifermin doses is carefully coordinated with your other treatments, so changes need to be managed by your medical professionals.
Your doctor might be able to adjust your schedule to accommodate the missed dose, or they might recommend proceeding with your treatment plan and monitoring you more closely for mouth sores. The decision depends on when the dose was missed and where you are in your treatment timeline.
Don't try to make up for a missed dose on your own. The medication schedule is specifically designed to provide optimal protection, and any changes should be made under medical supervision.
Q4:When Can I Stop Taking Palifermin?
You don't need to make the decision about when to stop palifermin because it's given as a predetermined course of treatment. The standard protocol involves six doses total, and once you've completed this course, the treatment is finished.
Your healthcare team will monitor your mouth and throat tissues throughout your cancer treatment to ensure the palifermin is providing the intended protection. They'll also watch for any signs that additional supportive care might be needed.
If you experience concerning side effects, your doctor might modify your treatment plan, but this decision will always be made in consultation with your entire medical team to ensure your safety and treatment success.
Q5:Can I Receive Palifermin During Pregnancy?
The use of palifermin during pregnancy requires very careful consideration by your medical team. There's limited data on how the medication affects pregnant women and developing babies, so it's typically reserved for situations where the benefits clearly outweigh potential risks.
If you're pregnant and need intensive cancer treatment, your doctors will work with specialists in high-risk pregnancy to develop the safest possible treatment plan. This might involve alternative approaches to preventing mouth sores or modified treatment protocols.
The decision will depend on factors like the type and stage of your cancer, how far along you are in your pregnancy, and what other treatment options are available. Your medical team will ensure you have all the information needed to make the best decision for both you and your baby.